MARKET

LUCD

LUCD

Lucid Diagnostics Inc.
NASDAQ
1.150
+0.030
+2.68%
Pre Market: 1.182 +0.032 +2.74% 04:02 04/01 EDT
OPEN
1.150
PREV CLOSE
1.150
HIGH
1.190
LOW
1.140
VOLUME
1
TURNOVER
0
52 WEEK HIGH
1.800
52 WEEK LOW
0.9495
MARKET CAP
203.49M
P/E (TTM)
-1.6614
1D
5D
1M
3M
1Y
5Y
1D
PAVMED INC - Q4 2025 NON-GAAP ADJ LOSS $0.9 MLN, $1.05 PER SHARE
Reuters · 1d ago
*Lucid Diagnostics 4Q Rev $52,000 >LUCD
Dow Jones · 1d ago
*Lucid Diagnostics 4Q Loss/Shr $2.05 >LUCD
Dow Jones · 1d ago
Press Release: PAVmed Provides Business Update -2-
Dow Jones · 1d ago
Analysts Offer Insights on Healthcare Companies: Lucid Diagnostics (LUCD), Vanda (VNDA) and Cytokinetics (CYTK)
TipRanks · 1d ago
Lucid Diagnostics Price Target Maintained With a $2.50/Share by BTIG
Dow Jones · 1d ago
BTIG Reiterates Buy on Lucid Diagnostics, Maintains $2.5 Price Target
Benzinga · 1d ago
Weekly Report: what happened at LUCD last week (0323-0327)?
Weekly Report · 2d ago
More
About LUCD
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics technology company. The Company is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, that leads to esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). The Company’s products include EsoGuard and EsoCheck. EsoGuard is a bisulfite-converted next generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in office procedures. It consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. It is also developing EsoCure, is an Esophageal Ablation Device, which is a technology that allows a clinician to treat dysplastic BE.

Webull offers Lucid Diagnostics Inc stock information, including NASDAQ: LUCD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LUCD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LUCD stock methods without spending real money on the virtual paper trading platform.